Rytr supports writing for over 30 languages, so you can easily create content in your native language.
FT Digital Edition: our digitised print edition
，更多细节参见91视频
Global news & analysis
The drug, called orforglipron and manufactured by Eli Lilly, is prescribed for type 2 diabetes and targets the same GLP-1 receptors as oral semaglutide. Like semaglutide, it lowers blood sugar levels, slows digestion and suppresses appetite. Unlike semaglutide tablets, it does not need to be taken on an empty stomach.